Decheng-Backed Cellular Research is Bought by BD Life Science
August 26, 2015 at 07:56 AM EDT
Cellular Research, a Silicon Valley genetics company supported by China's Decheng Capital, has been acquired by BD Life Sciences. BD Life Sciences is a division of medical technology company BD (Becton, Dickinson and Company). Cellular Research has developed a next-generation single cell preparation technology that, according to the company, "offers absolute quantification of gene expression with orders of magnitude improvement in throughput and cost." More details.... Stock Symbol: (NYSE: BDX) Share this with colleagues: // //